AYTU vs CNC · rev $66.4M vs P/E 8.4, rev $103.52B
Aytu BioScience Inc (AYTU) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
AYTU currently screens at market cap $24.1M. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the AYTU and CNC stock pages for the full models.
Not investment advice.